It was seen that treatment of secondary hyperparathyroidism by administration of cinacalcet resulted in increased hemoglobin levels [158,159,160,161,162] and was also associated with reduced FGF-23 levels [163] (Figure 4). Here, FGF23 is linked to secondary hyperparathyroidism.